uniQure N.V. (QURE) - 5i Research

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

AbbVie Inc. (ABBV $218.04)
- $218.04 P/E (TTM): 104.33X Cap: $385.18B
- View ABBV Profile
- View Questions on ABBV
Eli Lilly and Company (LLY $862.86)
- $862.86 P/E (TTM): 42.21X Cap: $815.73B
- View LLY Profile
- View Questions on LLY
Cipher Pharmaceuticals Inc. (CPH $14.80)
- $14.80 P/E (TTM): 22.96X Cap: $375M
- View CPH Profile
- View Questions on CPH
- View Reports on CPH
Halozyme Therapeutics Inc. (HALO $65.19)
- $65.19 P/E (TTM): 14.92X Cap: $7.62B
- View HALO Profile
- View Questions on HALO
uniQure N.V. (QURE $67.69)
- $67.69 Cap: $3.72B
- View QURE Profile
- View Questions on QURE
Catalyst Pharmaceuticals Inc. (CPRX $21.27)
- $21.27 P/E (TTM): 12.89X Cap: $2.60B
- View CPRX Profile
- View Questions on CPRX

Q: Hi, could you suggest a couple each of your fav. small, mid and large cap biotech stocks and why you like them.

thanks, M

Read Answer Asked by Mark on October 08, 2025

Q: What do you think of the prospects for these companies; ITRM, QURE, CEIX

Read Answer Asked by hal on August 10, 2023